Quarterly ResultAug 11, 2026, 08:42 AM
Syra Health Q2 Revenue +23% to $2.4M; Gross Margin 44.5%; Profitable
AI Summary
Syra Health Corp. announced strong financial results for the second quarter ended June 30, 2026, marking its second consecutive profitable quarter. The company reported a 23% year-over-year revenue increase to $2.4 million and significantly improved its gross margin to 44.5%. Net income reached $250,242, a substantial improvement from a net loss in the prior-year period, with EPS rising to $0.02. Operational highlights include contract extensions and progress towards CMS ACCESS Model approval, reinforcing the company's focus on sustained full-year profitability for 2026.
Key Highlights
- Q2 2026 revenue grew 23% year-over-year to $2.4 million.
- Net income for Q2 2026 was $250,242, compared to a net loss of $(63,596) in Q2 2025.
- Gross margin increased to 44.5% in Q2 2026, up from 38.7% in Q2 2025.
- Earnings per share (EPS) improved to $0.02 in Q2 2026 from a loss of $(0.01) in Q2 2025.
- EBITDA increased to $253,200 in Q2 2026 from a loss of $(53,760) in Q2 2025.
- Population health solutions revenue grew 8% year-over-year to $1.716 million.
- Healthcare workforce revenue increased 87% year-over-year to $678,113.
- Net cash provided by operating activities for H1 2026 was $643,183, up from $85,754 in H1 2025.
Price Impact
More from SYRA